Literature DB >> 24421390

The capable ABL: what is its biological function?

Jean Y J Wang1.   

Abstract

The mammalian ABL1 gene encodes the ubiquitously expressed nonreceptor tyrosine kinase ABL. In response to growth factors, cytokines, cell adhesion, DNA damage, oxidative stress, and other signals, ABL is activated to stimulate cell proliferation or differentiation, survival or death, retraction, or migration. ABL also regulates specialized functions such as antigen receptor signaling in lymphocytes, synapse formation in neurons, and bacterial adhesion to intestinal epithelial cells. Although discovered as the proto-oncogene from which the Abelson leukemia virus derived its Gag-v-Abl oncogene, recent results have linked ABL kinase activation to neuronal degeneration. This body of knowledge on ABL seems confusing because it does not fit the one-gene-one-function paradigm. Without question, ABL capabilities are encoded by its gene sequence and that molecular blueprint designs this kinase to be regulated by subcellular location-dependent interactions with inhibitors and substrate activators. Furthermore, ABL shuttles between the nucleus and the cytoplasm where it binds DNA and actin--two biopolymers with fundamental roles in almost all biological processes. Taken together, the cumulated results from analyses of ABL structure-function, ABL mutant mouse phenotypes, and ABL substrates suggest that this tyrosine kinase does not have its own agenda but that, instead, it has evolved to serve a variety of tissue-specific and context-dependent biological functions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421390      PMCID: PMC3993570          DOI: 10.1128/MCB.01454-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  83 in total

1.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 2.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

3.  c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.

Authors:  B B Brasher; R A Van Etten
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

4.  Essential roles for the Abl and Arg tyrosine kinases in neurulation.

Authors:  A J Koleske; A M Gifford; M L Scott; M Nee; R T Bronson; K A Miczek; D Baltimore
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

Review 5.  Mitophagy and Parkinson's disease: be eaten to stay healthy.

Authors:  Rosa L A de Vries; Serge Przedborski
Journal:  Mol Cell Neurosci       Date:  2012-08-02       Impact factor: 4.314

6.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

Review 7.  The role of apoptosis-induced proliferation for regeneration and cancer.

Authors:  Hyung Don Ryoo; Andreas Bergmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

8.  An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis.

Authors:  Anna Innocenzi; Lucia Latella; Graziella Messina; Marta Simonatto; Fabrizia Marullo; Libera Berghella; Coralie Poizat; Chih-Wen Shu; Jean Y J Wang; Pier Lorenzo Puri; Giulio Cossu
Journal:  EMBO Rep       Date:  2011-01-07       Impact factor: 8.807

9.  ABL1 regulates spindle orientation in adherent cells and mammalian skin.

Authors:  Shigeru Matsumura; Mayumi Hamasaki; Takuya Yamamoto; Miki Ebisuya; Mizuho Sato; Eisuke Nishida; Fumiko Toyoshima
Journal:  Nat Commun       Date:  2012-01-17       Impact factor: 14.919

10.  Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.

Authors:  Panagis Filippakopoulos; Michael Kofler; Oliver Hantschel; Gerald D Gish; Florian Grebien; Eidarus Salah; Philipp Neudecker; Lewis E Kay; Benjamin E Turk; Giulio Superti-Furga; Tony Pawson; Stefan Knapp
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

View more
  72 in total

1.  Structure of the ABL2/ARG kinase in complex with dasatinib.

Authors:  Byung Hak Ha; Mark Adam Simpson; Anthony J Koleske; Titus J Boggon
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

2.  Molecular convergence and positive selection associated with the evolution of symbiont transmission mode in stony corals.

Authors:  Groves B Dixon; Carly D Kenkel
Journal:  Proc Biol Sci       Date:  2019-04-24       Impact factor: 5.349

Review 3.  Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.

Authors:  Lauren Caldemeyer; Michael Dugan; John Edwards; Luke Akard
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

Review 4.  Diagnostic molecular techniques in haematology: recent advances.

Authors:  Aikaterini Koutsi; Elisavet-Christina Vervesou
Journal:  Ann Transl Med       Date:  2018-06

Review 5.  Optogenetically controlled protein kinases for regulation of cellular signaling.

Authors:  Anna V Leopold; Konstantin G Chernov; Vladislav V Verkhusha
Journal:  Chem Soc Rev       Date:  2018-04-03       Impact factor: 54.564

Review 6.  Multifunctional Abl kinases in health and disease.

Authors:  Aaditya Khatri; Jun Wang; Ann Marie Pendergast
Journal:  J Cell Sci       Date:  2016-01-01       Impact factor: 5.285

7.  The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage.

Authors:  Chi-Chiang Tu; Yan Zhong; Louis Nguyen; Aaron Tsai; Priya Sridevi; Woan-Yuh Tarn; Jean Y J Wang
Journal:  Sci Signal       Date:  2015-06-30       Impact factor: 8.192

8.  Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.

Authors:  Yashodhara Dasgupta; Mateusz Koptyra; Grazyna Hoser; Kanchan Kantekure; Darshan Roy; Barbara Gornicka; Margaret Nieborowska-Skorska; Elisabeth Bolton-Gillespie; Sabine Cerny-Reiterer; Markus Müschen; Peter Valent; Mariusz A Wasik; Christine Richardson; Oliver Hantschel; Heiko van der Kuip; Tomasz Stoklosa; Tomasz Skorski
Journal:  Blood       Date:  2016-02-10       Impact factor: 22.113

Review 9.  Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Svetlana Tafjord; Marius Lund-Iversen; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 10.  Attacking the supply wagons to starve cancer cells to death.

Authors:  Elizabeth M Selwan; Brendan T Finicle; Seong M Kim; Aimee L Edinger
Journal:  FEBS Lett       Date:  2016-03-22       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.